Select a community
All Communities
Home > Community Treatment Reports > Rasagiline Treatment Report
What is Rasagiline?

Rasagiline is an anti-Parkinson's agent and MAO inhibitor which can enhance the activity of dopamine. It is used for initial monotherapy or as adjunct to levodopa in the treatment of idiopathic Parkinson's disease.

Side Effects

Side effects as an overall problem

Severe
8 6%
Moderate
9 7%
Mild
25 18%
None
96 70%

Most commonly reported side effects

Urinary frequency
16 12%
Anxiety
11 8%
Headaches
8 6%
Difficulty falling asleep (sleep onset insomnia)
7 5%
severe skin rash
6 4%
Heart Palpitations
5 4%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Rasagiline. See all 11 dosages

  daily 0.05 mg daily 0.3 mg daily 0.5 mg daily 1 mg daily 1.5 mg daily 2 mg daily 3 mg daily 5 mg daily 6 mg daily 1000 mg daily
  20 Number of Patients: 20 2 Number of Patients: 2 1 Number of Patients: 1 80 Number of Patients: 80 393 Number of Patients: 393 3 Number of Patients: 3 4 Number of Patients: 4 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Rasagiline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
38 42% Side effects too severe: 42%
Did not seem to work
36 40% Did not seem to work: 40%
Doctor's advice
22 24% Doctor's advice: 24%
Other
14 16% Other: 16%
Expense
8 9% Expense: 9%
Personal research
7 8% Personal research: 8%
Not indicated
1 1% Not indicated: 1%

See all 88 patients who’ve stopped taking Rasagiline

Currently Taking Rasagiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
4
18
20
78
97
106

Stopped Taking Rasagiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
15
23
16
14
14
7

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
122 88%
Usually
12 9%
Sometimes
1 1%
Never
3 2%

Burden

Difficulty being on treatment

Very
9 7%
Somewhat
12 9%
A little
19 14%
Not at all
98 71%

Cost

Paid out of pocket

$200+
9 7%
$100-199
8 6%
$50-99
14 10%
$25-49
29 21%
< $25
45 33%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.